1. Home
  2. NICE vs KYMR Comparison

NICE vs KYMR Comparison

Compare NICE & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$106.26

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$72.35

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICE
KYMR
Founded
1986
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.4B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
NICE
KYMR
Price
$106.26
$72.35
Analyst Decision
Buy
Strong Buy
Analyst Count
13
24
Target Price
$162.31
$105.96
AVG Volume (30 Days)
751.5K
740.7K
Earning Date
02-19-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
35.79
N/A
EPS
8.79
N/A
Revenue
$2,880,503,000.00
$43,735,000.00
Revenue This Year
$9.57
$18.71
Revenue Next Year
$8.07
N/A
P/E Ratio
$11.76
N/A
Revenue Growth
9.24
N/A
52 Week Low
$99.00
$19.45
52 Week High
$180.61
$103.00

Technical Indicators

Market Signals
Indicator
NICE
KYMR
Relative Strength Index (RSI) 34.72 47.75
Support Level $106.00 $70.00
Resistance Level $117.21 $72.86
Average True Range (ATR) 3.73 3.44
MACD -0.83 0.04
Stochastic Oscillator 6.79 57.69

Price Performance

Historical Comparison
NICE
KYMR

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: